Capsinolol: The first β-adrenoceptor blocker with an associated calcitonin gene-related peptide releasing activity in the heart

British Journal of Pharmacology

Volumn 119, Issue 1, 1996, Pages 7-14

  Chen, I J ^a   Yeh, J L ^a   Lo, Y C ^a   Sheu, S H ^a   Lin, Y T ^a  

^a KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Calcitonin gene related peptide; Capsaicin analogues; Capsazepine; Cardiotonic activity; adrenoceptor blocker

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCITONIN GENE RELATED PEPTIDE; CAPSAZEPINE; CAPSINOLOL; ISOPRENALINE; PHENYLEPHRINE; PROPRANOLOL; RESERPINE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRADYCARDIA; CARDIOVASCULAR EFFECT; CHRONOTROPISM; CONTROLLED STUDY; GUINEA PIG; INOTROPISM; INTRAVENOUS DRUG ADMINISTRATION; ISOLATED HEART; NONHUMAN; PRESSOR RESPONSE; PRIORITY JOURNAL; TACHYCARDIA;

EID: 0029811699     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1476-5381.1996.tb15670.x     Document Type: Article

References (27)

1. ARUNLAKSHANA, O. & SCHILD, H.O. (1959). Some quantitative uses of drug antagonists. Br. J. Pharmacol., 14, 48 - 57.
2. BROADLEY, K.L, (1979). The Langendorff heart preparation: reappraisal of its role as a research and teaching model for coronary vasoactive drugs. J. Pharmacol. Methods, 2, 143-156.
3. BUCK, S.H. & BURKS, T.F. (1986). The neuropharmacology of capsaicin: review of some recent observations. Pharmacol. Rev., 38, 179 - 226.
4. CASTLE, N.A. (1992). Differential inhibition of potassium currents in rat ventricular myocytes by capsaicin. Cardiovasc. Res., 26, 1137 - 1144.
5. CHAHL, L.A. & LYNCH, A.M. (1987). The acute effects of capsaicin on the cardiovascular system. Acta. Physiol. Hung., 69, 413 - 419.
6. CHEN, I.J., YEH, J.L., LIOU, S.J. & SHEN, A.Y. (1994). Guaia-coxypropanolamine derivatives of capsaicin: A new family of β-adrenoceptor blockers with intrisic cardiotonic properties. J. Med. Chem., 37, 938 - 943.
7. CHEN, I.J., LIOU, S.J., LIOU, S.S. & LIN, C.N. (1993). Xanthonolol: A calcium channel and beta-adrenoceptor blocker with vasodilating properties. Gen. Pharmacol., 24, 1425 - 1433.
8. CHEN, I.J., YANG, J.M., YEH, J.L., WU, B.N., LO, Y.C. & CHEN, S.J. (1992). Hypotensive and antinociceptive effects of ether-linked and relatively non-pungent analogues of N-nonanoyl vanillylamide. Eur. J. Med. Cham., 27, 187 - 192.
9. CLARK, B.J., MENNINGER, K. & BERHOLET, A. (1982). Pindolol - The pharmacology of a partial agonist. Br. J. Clin. Pharmacol., 13, 149S - 158S.
10. D'ALONZO, A.J., GROVER, G.J., DARBENZIO, R.B., HESS, T.A., SLEH, G., DZWONCZYK, S., ZHU, J.L. & SEWTER, J.C. (1995). In vitro effects of capsaicin: antiarrhythmic and antiischaemic activity. Eur. J. Pharmacol., 272, 269 - 278.
11. DONNERER, J. & LEMBECK, F. (1982). Analysis of the effects of intravenously injected capsaicin in the rat. Naunyn-Schmiedeberg's Arch. Pharmacol., 320, 54 - 57.
12. FRANCO-CERECEDA, A., LUNDBERG, J.M., SARIA, A., SCHREIB-MAYER, W. & TRITTHART, H.A. (1988). Calcitonin gene-related peptide: Release by capsaicin and prolongation of the action potential in the guinea-pig heart. Acta Physiol. Scand., 132, 181 - 190.
13. FRANCO-CERECEDA, A., SARIA, A. & LUNDBERG, J.M. (1989). Differential release of calcitonin gene-related peptide and neuropeptide Y from the isolated heart by capsaicin, ischemia, nicotine, bradykinin and ouabin. Acta Physiol. Scand., 135, 173 - 187.
14. GENNARI, C., NAMI, R., AGNUSDEI, D. & FISCHER, J.A. (1990). Improved cardiac performance with human calcitonin gene-related peptide in patients with congestive heart failure. Cardiovasc. Res., 24, 239 - 241.
15. HIMORI, N., ISHIMORI, T., SHIRATSUCHI, K., TSUNEDA, K. & IZUMI, A. (1984). Role of beta 2-adrenoceptor blockade and circulating adrenaline level for the pressor responses to beta-adrenoceptor blocking drugs in rats. Naunyn-Schmiedeberg's Arch. Pharmacol., 325, 314 - 319.
16. HOFFMAN, B.B. & LEFKOWITZ, R.J. (1991). Adrenergic receptor antagonists. In The Pharmacological Basis of Therapeutics, 8th edition, ed. Gilman, A.G., Rall, T.W., Nies, A.S. & Taylor, P. pp. 221 243. New York: Pergamon Press Inc.
17. HOLZER, P. (1991). Capsaicin: cellular targets, mechanisms of action, and selectivity for the sensory neurons, Pharmacol. Rev., 43, 143 - 201.
18. 1-adrenoceptor antagonist. J. Cardiovasc. Pharmacol. (in press).
19. LO, Y.C., YEH, J.L., WU. J.R., YANG, J.M., CHEN, S.J. & CHEN, I.J. (1994). Autonomic and sensory cardiovascular activities of nonivamide: Intrathecal administration of clonidine. Brain Res. Bull., 35, 15 - 22.
20. LO, Y.C., WU, S.N., WU, J.R. & CHEN, I.J. (1995). Effect of capsaicin on membrane currents in cultured vascular smooth muscle cells of rat aorta. Eur. J. Pharmacol., 292, 321 - 328.
21. 2 values on guinea-pig trachea and atria. Naunyn-Schmiedeberg's Arch. Pharmacol., 308, 183 - 190.
22. OHMURA, T., NASHIO, M., KIGOSHI, S. & MURAMATSU, I. (1990). Electrophysiological and mechanical effects of calcitonin gene-related peptide on guinea-pig atria. Br. J. Pharmacol., 100, 27-30.
23. SEKIYA, A., YAMAMOTO, J. & MAEKAWA, H. (1974). Cardiovascular action of propranolol in rats under various anesthetic procedures. Jap. J. Pharmacol., 24, 879 - 883.
24. WU, B.N., YANG, C.R., YANG, J.M. & CHEN, I.J. (1994a). A new β-adrenoceptor blocking agent derived from dehydrozingerone. Gen. Pharmacol., 25, 651 - 659.
25. 1-adrenoceptor antagonist derived from vanillin. Biochem. Pharmacol., 48, 101 - 109.
26. WU, B.N. HO, W.C., CHIANG, L.C. & CHEN, I.J. (1996). Zingeronolol: A newly developed β-adrenergic blocking agent derived from zingerone, a pungent principle of ginger. Asia Pacific J. Pharmacol. (in press).
27. YEH, J.L., LO, Y.C., WANG, Y. & CHEN, I.J. (1993). Cardiovascular interactions of nonivamide, glyceryl nonivamide, capsaicin analogues, and substance P antagonist in rats. Brain Res. Bull., 30, 641 - 648.